{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T05:56:51Z","timestamp":1784527011884,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"publisher","award":["Ex-60%"],"award-info":[{"award-number":["Ex-60%"]}],"id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2010599KBR"],"award-info":[{"award-number":["2010599KBR"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Behav Brain Funct"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12993-017-0119-2","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T21:53:15Z","timestamp":1485381195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Drug-induced Parkinson\u2019s disease modulates protein kinase A and Olfactory Marker Protein in the mouse olfactory bulb"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5307-0414","authenticated-orcid":false,"given":"Carla","family":"Mucignat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Caretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,26]]},"reference":[{"key":"119_CR1","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/jnnp.62.5.436","volume":"62","author":"CH Hawkes","year":"1997","unstructured":"Hawkes CH, Shephard BC, Daniel SE. Olfactory dysfunction in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1997;62:436\u201346.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"119_CR2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res. 2004;318:121\u201334.","journal-title":"Cell Tissue Res"},{"key":"119_CR3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","volume":"61","author":"K Tredici Del","year":"2002","unstructured":"Del Tredici K, Rub U, De Vos RA, Bohl JR, Braak H. Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol. 2002;61:413\u201326.","journal-title":"J Neuropathol Exp Neurol"},{"key":"119_CR4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mds.870100309","volume":"10","author":"RK Pearce","year":"1995","unstructured":"Pearce RK, Hawkes CH, Daniel SE. The anterior olfactory nucleus in Parkinson\u2019s disease. Mov Disord. 1995;10:283\u20137.","journal-title":"Mov Disord"},{"key":"119_CR5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0140-6736(92)93275-R","volume":"340","author":"SE Daniel","year":"1992","unstructured":"Daniel SE, Hawkes CH. Preliminary diagnosis of Parkinson\u2019s disease by olfactory bulb pathology. Lancet. 1992;340:186.","journal-title":"Lancet"},{"key":"119_CR6","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/(SICI)1096-9861(19990906)411:4<666::AID-CNE10>3.0.CO;2-S","volume":"411","author":"NL Koster","year":"1999","unstructured":"Koster NL, Norman AB, Richtand NM, Nickell WT, Puche AC, Pixley SK, Shipley MT. Olfactory receptor neurons express D2 dopamine receptors. J Comp Neurol. 1999;411:666\u201373.","journal-title":"J Comp Neurol"},{"key":"119_CR7","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1460-9568.2005.04328.x","volume":"22","author":"M Gutierrez-Mecinas","year":"2005","unstructured":"Gutierrez-Mecinas M, Crespo C, Blasco-Ibanez JM, Gracia-Llanes FJ, Marques-Mari AI, Nacher J, Varea E, Martinez-Guijarro FJ. Distribution of D2 dopamine receptor in the olfactory glomeruli of the rat olfactory bulb. Eur J Neurosci. 2005;22:1357\u201367.","journal-title":"Eur J Neurosci"},{"key":"119_CR8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0306-4522(93)90119-Z","volume":"57","author":"BL Mania-Farnell","year":"1993","unstructured":"Mania-Farnell BL, Farbman AI, Bruch RC. Bromocriptine, a dopamine D2 receptor agonist, inhibits adenylyl cyclase activity in rat olfactory epithelium. Neuroscience. 1993;57:173\u201380.","journal-title":"Neuroscience"},{"key":"119_CR9","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1073\/pnas.96.5.2456","volume":"96","author":"I Bruenig","year":"1999","unstructured":"Bruenig I, Sommer M, Hatt H, Borkmann J. Dopamine receptor subtypes modulate olfactory bulb gamma-aminobutyric acid type A receptors. Proc Natl Acad Sci USA. 1999;96:2456\u201360.","journal-title":"Proc Natl Acad Sci USA"},{"key":"119_CR10","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1097\/00001756-200110290-00029","volume":"29","author":"Z Liu","year":"2001","unstructured":"Liu Z, Zhang J, Fei J, Guo L. A novel mechanism of dopamine neurotoxicity involving the peripheral extracellular and the plasma membrane dopamine transporter. NeuroReport. 2001;29:3293\u20137.","journal-title":"NeuroReport"},{"key":"119_CR11","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1046\/j.1471-4159.2002.00875.x","volume":"81","author":"F Riederer","year":"2002","unstructured":"Riederer F, Luborzewski A, God R, Bringmann G, Scholz J, Feineis D, Moser A. Modification of tyrosine hydroxylase activity by chloral derived \u03b2-carbolines in vitro. J Neurochem. 2002;81:814\u20139.","journal-title":"J Neurochem"},{"key":"119_CR12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(97)00355-8","volume":"228","author":"JD Oh","year":"1997","unstructured":"Oh JD, Del Dotto P, Chase TN. Protein kinase A inhibitor attenuates levodopa-induced motor response alterations in the hemi-parkinsonian rat. Neurosci Lett. 1997;228:5\u20138.","journal-title":"Neurosci Lett"},{"key":"119_CR13","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1523\/JNEUROSCI.2702-13.2014","volume":"34","author":"T Fieblinger","year":"2014","unstructured":"Fieblinger T, Sebastianutto I, Alcacer C, Fieblinger T, Sebastianutto I, Alcacer C, Bimpisidis Z, Maslava N, Sandberg S, Engblom D, Cenci MA, et al. Mechanisms of dopamine D1 receptor-mediated ERK1\/2 activation in the parkinsonian striatum and their modulation by metabotropic glutamate receptor type 5. J Neurosci. 2014;34:4728\u201340.","journal-title":"J Neurosci"},{"key":"119_CR14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbrc.2015.07.125","volume":"465","author":"I Kawahata","year":"2015","unstructured":"Kawahata I, Ohtaku S, Tomioka Y, Ichinose H, Yamakuni T. Dopamine or biopterin deficiency potentiates phosphorylation at (40)Ser and ubiquitination of tyrosine hydroxylase to be degraded by the ubiquitin proteasome system. Biochem Biophys Res Commun. 2015;465:53\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"119_CR15","doi-asserted-by":"crossref","first-page":"E34","DOI":"10.1073\/pnas.1312701111","volume":"111","author":"K Muda","year":"2014","unstructured":"Muda K, Bertinetti D, Gesellchen F, Hermann JS, von Zweydorf F, Geerlof A, Jacob A, Ueffing M, Gloeckner CJ, Herberg FW. Parkinson-related LRRK2 mutation R1441C\/G\/H impairs PKA phosphorylation of LRRK2 and disrupts its interaction with 14-3-3. Proc Natl Acad Sci USA. 2014;111:E34\u201343.","journal-title":"Proc Natl Acad Sci USA"},{"key":"119_CR16","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1074\/jbc.M110.178905","volume":"286","author":"HY Qureshi","year":"2011","unstructured":"Qureshi HY, Paudel HK. Parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and alpha-synuclein mutations promote Tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro. J Biol Chem. 2011;286:5055\u201368.","journal-title":"J Biol Chem"},{"key":"119_CR17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-4419-0322-8_2","volume":"651","author":"JW Cave","year":"2009","unstructured":"Cave JW, Baker H. Dopamine systems in the forebrain. Adv Exp Med Biol. 2009;651:15\u201335.","journal-title":"Adv Exp Med Biol"},{"key":"119_CR18","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nrn2216","volume":"8","author":"MA Curtis","year":"2007","unstructured":"Curtis MA, Faull RL, Eriksson PS. The effect of neurodegenerative diseases on the subventricular zone. Nat Rev Neurosci. 2007;8:712\u201323.","journal-title":"Nat Rev Neurosci"},{"key":"119_CR19","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nn1265","volume":"7","author":"GU Hoeglinger","year":"2004","unstructured":"Hoeglinger GU, Rizk P, Muriel MP, Duyckaerts C, Oertel WH, Caille I, Hirsch EC. Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neurosci. 2004;7:726\u201335.","journal-title":"Nat Neurosci"},{"key":"119_CR20","doi-asserted-by":"crossref","first-page":"10105","DOI":"10.1523\/JNEUROSCI.3512-05.2005","volume":"25","author":"C Giachino","year":"2005","unstructured":"Giachino C, De Marchis S, Giampietro C, Parlato R, Perroteau I, Schuetz G, Fasolo A, Peretto P. cAMP response element-binding protein regulates differentiation and survival of newborn neurons in the olfactory bulb. J Neurosci. 2005;25:10105\u201318.","journal-title":"J Neurosci"},{"key":"119_CR21","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.nbd.2004.03.007","volume":"16","author":"C Mucignat-Caretta","year":"2004","unstructured":"Mucignat-Caretta C, Bondi\u2019 M, Caretta A. Animal models of depression: olfactory lesions affect amygdala, subventricular zone, and aggression. Neurobiol Dis. 2004;16:386\u201395.","journal-title":"Neurobiol Dis"},{"key":"119_CR22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","volume":"125","author":"M Sedelis","year":"2001","unstructured":"Sedelis M, Schwarting RKW, Huston JP. Behavioral phenotyping of the MPTP mouse model of Parkinson\u2019s disease. Behav Brain Res. 2001;125:109\u201322.","journal-title":"Behav Brain Res"},{"key":"119_CR23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jchemneu.2004.03.006","volume":"27","author":"C Mucignat-Caretta","year":"2004","unstructured":"Mucignat-Caretta C, Caretta A. Regional variations in the localization of insoluble kinase A regulatory isoforms during rodent brain development. J Chem Neuroanat. 2004;27:201\u201312.","journal-title":"J Chem Neuroanat"},{"key":"119_CR24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24:197\u2013211.","journal-title":"Neurobiol Aging"},{"key":"119_CR25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neubiorev.2016.03.016","volume":"65","author":"T Asakawa","year":"2016","unstructured":"Asakawa T, Fang H, Sugiyama K, Nozaki T, Hong Z, Yang Y, Hua F, Ding G, Chao D, Fenoy AJ, Villarreal SJ, Onoe H, Suzuki K, Mori N, Namba H, Xia Y. Animal behavioral assessments in current research of Parkinson\u2019s disease. Neurosci Biobehav Rev. 2016;65:63\u201394.","journal-title":"Neurosci Biobehav Rev"},{"key":"119_CR26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00335-011-9330-x","volume":"22","author":"PMA Antony","year":"2011","unstructured":"Antony PMA, Diederich NJ, Balling R. Parkinson\u2019s disease mouse models in translational research. Mamm Genome. 2011;22:401\u201319.","journal-title":"Mamm Genome"},{"key":"119_CR27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pbb.2004.03.006","volume":"78","author":"R Kurosaki","year":"2004","unstructured":"Kurosaki R, Muramatsu Y, Kato H, Araki T. Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson\u2019s disease. Pharmacol Biochem Behav. 2004;78:143\u201353.","journal-title":"Pharmacol Biochem Behav"},{"key":"119_CR28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ana.410320116","volume":"32","author":"RL Doty","year":"1992","unstructured":"Doty RL, Singh A, Tetrud J, Langston JW. Lack of major olfactory dysfunction in MPTP-induced parkinsonism. Ann Neurol. 1992;32:97\u2013100.","journal-title":"Ann Neurol"},{"issue":"10","key":"119_CR29","doi-asserted-by":"crossref","first-page":"e77509","DOI":"10.1371\/journal.pone.0077509","volume":"8","author":"S Kurtenbach","year":"2013","unstructured":"Kurtenbach S, Wewering S, Hatt H, Neuhaus EM, L\u00fcbbert H. Olfaction in three genetic and two MPTP-induced Parkinson\u2019s disease mouse models. PLoS ONE. 2013;8(10):e77509.","journal-title":"PLoS ONE"},{"key":"119_CR30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000118880","volume":"36","author":"RG Brown","year":"1996","unstructured":"Brown RG, Jahanshahi M. Cognitive-motor dysfunction in Parkinson\u2019s disease. Eur Neurol. 1996;36:24\u201331.","journal-title":"Eur Neurol"},{"key":"119_CR31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","volume":"15","author":"W Poewe","year":"2008","unstructured":"Poewe W. Non-motor symptoms in Parkinson\u2019s disease. Eur J Neurol. 2008;15:14\u201320.","journal-title":"Eur J Neurol"},{"key":"119_CR32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1460-9568.2008.06346.x","volume":"28","author":"SM Fleming","year":"2008","unstructured":"Fleming SM, Tetreault NA, Mulligan CK, Hutson CB, Masliah E, Chesselet MF. Olfactory deficits in mice overexpressing human wildtype \u03b1-synuclein. Eur J Neurosci. 2008;28:247\u201356.","journal-title":"Eur J Neurosci"},{"key":"119_CR33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/syn.20089","volume":"55","author":"Z Xu","year":"2005","unstructured":"Xu Z, Cawthon D, McCastlain KA, Slikker W Jr, Ali SF. Selective alterations of gene expression in mice induced by MPTP. Synapse. 2005;55:45\u201351.","journal-title":"Synapse"},{"key":"119_CR34","doi-asserted-by":"crossref","first-page":"25375","DOI":"10.1074\/jbc.271.41.25375","volume":"271","author":"C Tinti","year":"1996","unstructured":"Tinti C, Conti B, Cubells JF, Kim KS, Baker H, Joh TH. Inducible cAMP Early Repressor can modulate tyrosine hydroxylase gene expression after stimulation of cAMP synthesis. J Biol Chem. 1996;271:25375\u201381.","journal-title":"J Biol Chem"},{"key":"119_CR35","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1471-4159.1987.tb09996.x","volume":"49","author":"R Cash","year":"1987","unstructured":"Cash R, Raisman R, Ploska A, Agid Y. Dopamine D-1 receptor and cyclic AMP-dependent phosphorylation in Parkinson\u2019s disease. J Neurochem. 1987;49:1075\u201383.","journal-title":"J Neurochem"},{"key":"119_CR36","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1124\/mol.105.012302","volume":"68","author":"T Andoh","year":"2005","unstructured":"Andoh T, Chock PB, Murphy DL, Chiueh CC. Role of the redox protein thioredoxin in cytoprotective mechanism evoked by (\u2013)-deprenyl. Mol Pharmacol. 2005;68:1408\u201314.","journal-title":"Mol Pharmacol"},{"key":"119_CR37","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1111\/j.1460-9568.1995.tb01041.x","volume":"7","author":"P Hulley","year":"1995","unstructured":"Hulley P, Hartikka J, Abdel\u2019Al S, Engels P, Buerki HR, Wiederhold KH, Muller T, Kelly P, Lowe D, Lubbert H. Inhibitors of type IV phosphodiesterases reduce the toxicity of MPTP in substantia nigra neurons in vivo. Eur J Neurosci. 1995;7:2431\u201340.","journal-title":"Eur J Neurosci"},{"key":"119_CR38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0014-2999(98)00497-X","volume":"357","author":"EA Young","year":"1998","unstructured":"Young EA, Duchemin AM, Neff NH, Hadjiconstantinou M. Parallel modulation of striatal dopamine synthetic enzymes by second messenger pathways. Eur J Pharmacol. 1998;357:15\u201323.","journal-title":"Eur J Pharmacol"},{"key":"119_CR39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.expneurol.2003.12.012","volume":"187","author":"R Betarbet","year":"2004","unstructured":"Betarbet R, Poisik O, Sherer TB, Greenamyre JT. Differential expression and Ser 897 phosphorylation of striatal N-methyl-d-aspartate receptor subunit NR1 in animal models of Parkinson\u2019s disease. Exp Neurol. 2004;187:76\u201385.","journal-title":"Exp Neurol"},{"key":"119_CR40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neuroscience.2003.10.040","volume":"124","author":"M Yamada","year":"2004","unstructured":"Yamada M, Onodera M, Mizuno Y, Mochizuki H. Neurogenesis in olfactory bulb identified by retroviral labeling in normal and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated adult mice. Neuroscience. 2004;124:173\u201381.","journal-title":"Neuroscience"},{"key":"119_CR41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.expneurol.2005.08.028","volume":"197","author":"B Winner","year":"2006","unstructured":"Winner B, Geyer M, Couillard-Despres S, Aigner R, Bogdahn U, Aigner L, Kuhn G, Winkler J. Striatal deafferentiation increases dopaminergic neurogenesis in the adult olfactory bulb. Exp Neurol. 2006;197:113\u201321.","journal-title":"Exp Neurol"},{"key":"119_CR42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neures.2004.09.012","volume":"51","author":"Y Mitsumoto","year":"2005","unstructured":"Mitsumoto Y, Mori A, Ohashi S, Nakai M, Moriizumi T. Differential effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the olfactory bulb and the striatum in mice. Neurosci Res. 2005;51:111\u20135.","journal-title":"Neurosci Res"}],"container-title":["Behavioral and Brain Functions"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12993-017-0119-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T05:04:31Z","timestamp":1498367071000},"score":1,"resource":{"primary":{"URL":"http:\/\/behavioralandbrainfunctions.biomedcentral.com\/articles\/10.1186\/s12993-017-0119-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,26]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["119"],"URL":"https:\/\/doi.org\/10.1186\/s12993-017-0119-2","relation":{},"ISSN":["1744-9081"],"issn-type":[{"value":"1744-9081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,26]]},"article-number":"1"}}